Redefining the HER2 Oncobiomarker: A Relevant Case Report
Journal Title: Journal of Oncobiomarkers - Year 2017, Vol 3, Issue 1
Abstract
In multiple studies anti HER2 therapy combined with chemotherapy demonstrated a marked improvement in disease free survival as adjuvant therapy and as treatment for metastatic breast cancer compared to chemotherapy alone for patients with tumors defined as being HER2 positive [1]. Because of these remarkable results, an expert ASCO/CAP panel in 2013 expanded the definitions of HER2 positive tumors with the hope of allowing more patients to receive and potentially benefit from receiving anti HER2 therapy [2].
Authors and Affiliations
Steven Sorscher
Keywords
Related Articles
- EP ID EP245952
- DOI 10.13188/2325-2340.1000013
- Views 96
- Downloads 0
Low Cell Density Induced Epithelial-Mesenchymal Transition in MCF10A Cell is Regulated by Proteasome Activity
Epithelial-mesenchymal transition (EMT) is a key process in tumor progression and metastasis. Previous studies have shown that MCF10A human mammary epithelial cells undergo EMT when cultured at low cell density, but...
Recent Advances in Managementof Prostate Cancer
Prostate cancer is the second most common cancer in males worldwide and the incidence is increasing due to ageing population, screening facilities and rising awareness. This is a disease of the elderly and is biologicall...
KSHV Down-regulates Tropoelastin in Both an in-vitro and in-vivo Kaposi’s Sarcoma Model
Kaposi’s sarcoma (KS), a common cancer in individuals with HIV/ AIDS, lacks a curative therapy. Few studies have examined changes in extracellular matrix (ECM) protein profiles in the development of KS. Here we used an i...
The Relative Fewness of Renal Metastases in Lung Cancer is Probably Explicable with the “Erythrocyte Associated Necrosis Factor” which may be an Oncobiomarker
There is profundity of lung cancer cells thrown into the circulation with each heart beat and the quantity of the quarter of the cardiac stroke volume being delivered to the kidneys. Despite both of these attractive attr...
Extracellular Domain Mutation of ErbB2 Status in Japanese Lung Cancer Patients
Purpose: The erbB pathway involves a family of tyrosine kinases and has contributed to resistance or sensitivity for chemotherapy in many tumor types. Somatic mutations of the erbB family receptor gene at kinase domain w...